<DOC>
	<DOC>NCT00428701</DOC>
	<brief_summary>This study is being done to see if Nexium I.V. can reduce and control stomach acid in mechanically ventilated, critically ill patients in an Intensive Care Unit setting.</brief_summary>
	<brief_title>An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium</brief_title>
	<detailed_description />
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Stomach Ulcer</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Critically ill male or female subjects 18 years or older who have a baseline gastric aspirate pH less then or equal to 4 Subjects admitted to an ICU requiring mechanically ventilated Subjects will have at least one additional stress ulcer risk factor Anticipated use of prepyloric enteral feeding after screening until the end of study Physician estimated survival of less then 96 hours Anticipation of major surgery within 96 hours of study enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>stress ulcer</keyword>
	<keyword>critically ill</keyword>
	<keyword>gastric acid</keyword>
	<keyword>gastric aspirates</keyword>
	<keyword>esomeprazole</keyword>
</DOC>